These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 28113516)

  • 1. Petri net siphon analysis and graph theoretic measures for identifying combination therapies in cancer.
    Behinaein B; Rudie K; Sangrar W
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(1):231-243. PubMed ID: 28113516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topological analysis of metabolic networks based on petri net theory.
    Zevedei-Oancea I; Schuster S
    Stud Health Technol Inform; 2011; 162():17-37. PubMed ID: 21685562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topological analysis of metabolic networks based on Petri net theory.
    Zevedei-Oancea I; Schuster S
    In Silico Biol; 2003; 3(3):323-45. PubMed ID: 12954094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells.
    Lee S; Heinrich EL; Lu J; Lee W; Choi AH; Luu C; Chung V; Fakih M; Kim J
    Pancreas; 2016 Feb; 45(2):286-92. PubMed ID: 26262587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer.
    Shin SY; Müller AK; Verma N; Lev S; Nguyen LK
    PLoS Comput Biol; 2018 Jun; 14(6):e1006192. PubMed ID: 29920512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximal class of weakly live ordinary Petri nets without emptiable siphons.
    Chao DY
    IEEE Trans Syst Man Cybern B Cybern; 2006 Dec; 36(6):1332-41. PubMed ID: 17186809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplified Ras-MAPK signal states correlate with accelerated EGFR internalization, cytostasis and delayed HER2 tumor onset in Fer-deficient model systems.
    Sangrar W; Shi C; Mullins G; LeBrun D; Ingalls B; Greer PA
    Oncogene; 2015 Jul; 34(31):4109-17. PubMed ID: 25347743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug development for cancer chemoprevention: focus on molecular targets.
    Johnson KA; Brown PH
    Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulating ATO Mechanism and EGFR Signaling with Fuzzy Logic and Petri Net.
    Shafiekhani S; Poursheykhani A; Rahbar S; Jafari AH
    J Biomed Phys Eng; 2021 Jun; 11(3):325-336. PubMed ID: 34189121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.
    Benvenuti S; Sartore-Bianchi A; Di Nicolantonio F; Zanon C; Moroni M; Veronese S; Siena S; Bardelli A
    Cancer Res; 2007 Mar; 67(6):2643-8. PubMed ID: 17363584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing digraph and Petri net approaches to deadlock avoidance in FMS.
    Fanti MP; Maione B; Turchiano B
    IEEE Trans Syst Man Cybern B Cybern; 2000; 30(5):783-98. PubMed ID: 18252409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
    Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
    Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined targeting of Raf and Mek synergistically inhibits tumorigenesis in triple negative breast cancer model systems.
    Nagaria TS; Shi C; Leduc C; Hoskin V; Sikdar S; Sangrar W; Greer PA
    Oncotarget; 2017 Oct; 8(46):80804-80819. PubMed ID: 29113345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug targets for tumorigenesis: insights from structural analysis of EGFR signaling network.
    Durmuş Tekir S; Yalçin Arga K; Ulgen KO
    J Biomed Inform; 2009 Apr; 42(2):228-36. PubMed ID: 18790083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.
    Martinelli E; Morgillo F; Troiani T; Ciardiello F
    Cancer Treat Rev; 2017 Feb; 53():61-69. PubMed ID: 28073102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Topology Potential-Based Method for Identifying Essential Proteins from PPI Networks.
    Li M; Lu Y; Wang J; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(2):372-83. PubMed ID: 26357224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining functional and topological properties to identify core modules in protein interaction networks.
    Lubovac Z; Gamalielsson J; Olsson B
    Proteins; 2006 Sep; 64(4):948-59. PubMed ID: 16794996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of EGER-related cancer drug resistance.
    Wei X
    Anticancer Drugs; 2011 Nov; 22(10):963-70. PubMed ID: 21822122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.